Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
1 NEW September 25, 2023
Are revisions to remdesivir dosing needed for treating SARS-CoV-2?

Are revisions to remdesivir dosing needed for treating SARS-CoV-2?

From the Schiffer lab, Clinical Research and Vaccine and Infectious Disease Divisions
Science SpotlightJuly 18, 2022
Mathematical modeling and phylodynamics of HIV intrahost evolution

Mathematical modeling and phylodynamics of HIV intrahost evolution

From the Schiffer Lab, Vaccine and Infectious Disease Division
Science SpotlightMarch 21, 2022
Modeling the kinetics of an HIV cure

Modeling the kinetics of an HIV cure

From the Schiffer group, Vaccine and Infectious Disease Division
Science SpotlightFebruary 15, 2021
Celebrate safely: Scientists offer advice, urge vigilance during holidays

Celebrate safely: Scientists offer advice, urge vigilance during holidays

'Now is the time for delayed gratification' — so skip big gatherings and travel to prevent the spread of COVID-19
Hutch NewsNovember 20, 2020
From the freezers, a speedier way to evaluate antiviral drugs

From the freezers, a speedier way to evaluate antiviral drugs

Lookback research showed today’s ‘viral load’ measurements and machine learning quickly mirrored outcomes of older, slower trials
Hutch NewsNovember 09, 2020
Imperfect, widely used measures best option against COVID-19, argues Dr. Joshua Schiffer

Imperfect, widely used measures best option against COVID-19, argues Dr. Joshua Schiffer

We need tests, masks, treatments and vaccines to be widespread, not perfect, says infectious disease expert in New York Times editorial
Hutch NewsOctober 05, 2020